Intracellular absorbed dose distribution in radioimmunotherapy: An example for B-cell lymphoma with leukemic spread

Research output: Contribution to journalArticle

Abstract

Patients with B-cell lymphoma may have disease manifestations ranging in size from more than a 1000 cm3 down to the volume of a single cell. If targeted radionuclide therapy is to become a curative treatment, all individual tumor cells must also be eliminated. Given the vast differences in particle energy of different electron- emitting radionuclides, one questions whether the mean absorbed dose is a relevant parameter for use in single-cell dosimetry and whether it would not be more accurate to adopt a stochastic approach to dosimetry.

Bibliographical metadata

Original languageEnglish
Pages (from-to)224-30
JournalCancer Biotherapy and Radiopharmaceuticals
Volume20
Issue number2
Publication statusPublished - 2005